3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
20
Myelodysplastic Syndromes
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Hodgkin Disease
10
Hematologic Neoplasms
10
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Lymphoma, Non-Hodgkin
8
Leukemia
8
Myeloproliferative Disorders
7
Multiple Myeloma
6
Leukemia, Myelomonocytic, Chronic
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Graft vs Host Disease
6
Waldenstrom Macroglobulinemia
5
Lymphoma
5
Leukemia, Biphenotypic, Acute
5
Anemia, Refractory, with Excess of Blasts
5
Lymphoma, Mantle-Cell
4
Lymphoma, Large B-Cell, Diffuse
4
Primary Myelofibrosis
3
Myelodysplastic-Myeloproliferative Diseases
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Prolymphocytic
3
Congenital Abnormalities
3
Blast Crisis
3
Anemia, Aplastic
3
Thrombocythemia, Essential
2
Sezary Syndrome
2
Recurrence
2
Interventions
Nivolumab
37
pembrolizumab
30
cabozantinib
27
Specimen Handling
25
Magnetic Resonance Spectroscopy
22
Ipilimumab
20
lenvatinib
16
Axitinib
15
belzutifan
13
CTLA-4 Antigen
10
Sunitinib
9
Biopsy
9
Radiosurgery
8
atezolizumab
7
Immunoglobulin G
5
toripalimab
4
fludarabine
4
avelumab
4
aldesleukin
4
Everolimus
4
Disulfides
4
Cyclophosphamide
4
zimberelimab
3
tivozanib
3
spartalizumab
3
pazopanib
3
palbociclib
3
durvalumab
3
cemiplimab
3
X-Rays
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Mycophenolic Acid
×
90 days
×
Clear all
No trials found.